Health outcomes of newborns from assisted reproductive technology
Prospective Cohort Study for Newborns From Patients Treated With ART in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)
This study looks at the health of babies born through assisted reproductive technology to see how it affects their short- and long-term well-being.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | N/A to 40 Years |
| Sex | All |
| Sponsor | The First Affiliated Hospital of Zhengzhou University Academic / other |
| Locations | 1 site (Zhengzhou, Henan) |
| Trial ID | NCT03993158 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the short- and long-term health consequences for newborns born to parents who underwent assisted reproductive technology (ART) at the Reproductive Medical Center of the First Affiliated Hospital of Zhengzhou University. The study utilizes a comprehensive database that includes medical records of both parents and newborns to collect biological samples, questionnaires, and health data. By analyzing this information, the study aims to provide valuable insights into the health prognosis of these children, which has been largely unknown until now.
Who should consider this trial
Good fit: Ideal candidates for this study are newborns from parents who have received ART treatment at the participating center.
Not a fit: Patients who have not undergone ART or whose newborns were not delivered at the participating center may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide critical information on the health outcomes of newborns conceived through ART, guiding future medical care and parental counseling.
How similar studies have performed: While there have been studies on ART outcomes, this specific cohort analysis focusing on long-term health consequences in newborns is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All newborns from patients treated with ART in our center. Exclusion Criteria: \-
Where this trial is running
Zhengzhou, Henan
- Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University — Zhengzhou, Henan, China (Recruiting)
Study contacts
- Study coordinator: Lanlan Fang, M.D.
- Email: fanglly@163.com
- Phone: 13673355291
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.